Neurovascular Protection by Adropin in Ischemic Stroke
Adropin 在缺血性中风中的神经血管保护作用
基本信息
- 批准号:10161626
- 负责人:
- 金额:$ 34.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-01 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAgeAlteplaseAnatomyAnimal ModelAttenuatedBasic ScienceBiological AvailabilityBlood - brain barrier anatomyBlood VesselsBlood flowBrainBrain InjuriesBrain IschemiaCellsCerebral IschemiaCerebral hemisphere hemorrhageClinical ResearchDataDevelopmentDiabetes MellitusEndotheliumEnzyme-Linked Immunosorbent AssayExposure toExtravasationFlow CytometryFoundationsFunctional disorderGelatinase BGenerationsGenesGoalsHomeostasisHospitalsHumanHyperlipidemiaImmunoblottingIncidenceInfarctionInjuryIschemiaIschemic StrokeKnockout MiceKnowledgeMagnetic Resonance ImagingMeasurementMediatingMediator of activation proteinMetabolismMissionModelingMolecularMusMyocardial IschemiaNADPH OxidaseNOS3 geneNational Institute of Neurological Disorders and StrokeNeurological outcomeNitric OxideNon-Insulin-Dependent Diabetes MellitusObesityOxidative StressPathogenesisPeptidesPermeabilityPeroxonitritePharmaceutical PreparationsPhosphorylationPlasmaPlasma ProteinsPlayProductionPublic HealthRattusReactionRecovery of FunctionRegulationReporterResearchRisk FactorsRoleStrokeSuperoxidesTechniquesTestingTherapeuticTherapeutic UsesTimeTransgenic MiceTumor-infiltrating immune cellsVascular Endothelial CellWild Type MouseWorkagedangiogenesisbasebehavioral outcomeblood damageblood-brain barrier functionblood-brain barrier permeabilizationbrain endothelial cellclinically relevantcognitive testingcomorbiditydisabilityendothelial dysfunctionexpectationexperimental studygenetic approachhuman diseaseimprovedinnovationinsulin sensitivitymortalitymouse modelnervous system disorderneurogenesisneuroinflammationneurological recoveryneuron lossneuroprotectionneurotoxicityneurovascularneurovascular injuryneurovascular unitnovelnovel strategiesnovel therapeutic interventionoverexpressionpolypeptidepost strokepre-clinicalprotective effectprotective efficacysexstroke modelstroke outcomestroke patient
项目摘要
ABSTRACT
Adropin is a recently identified and highly conserved polypeptide abundantly expressed in the brain. Adropin
plays a critical role in the regulation of endothelial function, insulin sensitivity, and metabolism. Recent findings
from our group and others reveal that adropin can significantly reduce endothelial permeability in rat brain and
human vascular endothelial cells. Clinical studies show a significant association between low plasma levels of
adropin and endothelial dysfunction in several human diseases. Endothelial dysfunction is one of the critical
factors contributing to the pathogenesis of ischemic stroke. Deficient production of nitric oxide (NO) by
endothelial nitric oxide synthase (eNOS) is a key factor contributing to endothelial dysfunction in diabetes,
obesity, and hyperlipidemia, which are important risks factors for stroke. Our hypothesis is that adropin confers
protection against ischemic stroke injury by reducing damage to the blood-brain barrier (BBB)/neurovascular
unit. Our overall goal in this proposal is to demonstrate the protective role of adropin in ischemic stroke and
investigate the underlying molecular mechanisms of this protection. Our preliminary data support this hypothesis
by showing that treatment with synthetic adropin dramatically reduces brain injury in a mouse stroke model,
which was associated with a significant increase in eNOS phosphorylation and reduced BBB damage. Moreover,
adropin protection was completely abolished in eNOS deficient mice suggesting an eNOS-dependent
mechanism underlying the protective effects of adropin in stroke. Aim 1 is to determine the effects of adropin
treatment on infarct size and long-term functional recovery in a mouse model of ischemic stroke. In Aim 2, we
will determine the ability of adropin to reduce the detrimental effects of endothelial dysfunction, oxidative stress,
and neuroinflammation on BBB function following ischemic stroke. In Aim 3, we will test the neuroprotective
efficacy of adropin in relation to age, sex, species, and comorbid conditions (obesity and diabetes). It is our
expectation that this study will provide significant knowledge on the protective efficacy of adropin in ischemic
stroke. Such results would be expected to have an important positive impact, since they would set the stage for
expanded preclinical work on the protective efficacy of adropin in cerebral ischemia, and would identify novel
and much-needed approaches to reduce the devastating consequences of neurovascular injury after stroke.
抽象的
Adropin 是最近发现的一种高度保守的多肽,在大脑中大量表达。阿德罗平
在内皮功能、胰岛素敏感性和代谢的调节中起着关键作用。最近的发现
我们小组和其他人的研究表明,adropin 可以显着降低大鼠大脑中的内皮细胞通透性,
人血管内皮细胞。临床研究表明低血浆水平之间存在显着关联
adropin 和几种人类疾病中的内皮功能障碍。内皮功能障碍是关键因素之一
影响缺血性中风发病机制的因素。一氧化氮 (NO) 生成不足
内皮一氧化氮合酶(eNOS)是导致糖尿病内皮功能障碍的关键因素,
肥胖、高脂血症是中风的重要危险因素。我们的假设是 adropin 赋予
通过减少对血脑屏障 (BBB)/神经血管的损害来预防缺血性中风损伤
单元。我们在本提案中的总体目标是证明阿德洛平在缺血性中风和中风中的保护作用
研究这种保护的潜在分子机制。我们的初步数据支持这一假设
通过证明合成阿德洛品治疗可显着减少小鼠中风模型中的脑损伤,
这与 eNOS 磷酸化的显着增加和血脑屏障损伤的减少有关。而且,
eNOS 缺陷小鼠中 adropin 的保护作用完全消失,表明 eNOS 依赖性
adropin 对中风的保护作用的机制。目标 1 是确定 adropin 的作用
对缺血性中风小鼠模型的梗死面积和长期功能恢复的治疗。在目标 2 中,我们
将确定 adropin 减少内皮功能障碍、氧化应激、
缺血性中风后神经炎症对血脑屏障功能的影响。在目标 3 中,我们将测试神经保护作用
adropin 的功效与年龄、性别、物种和合并症(肥胖和糖尿病)有关。这是我们的
期望这项研究将为阿德洛平在缺血性脑损伤中的保护功效提供重要的知识。
中风。这些结果预计将产生重要的积极影响,因为它们将为
扩大了阿德洛平对脑缺血保护作用的临床前研究,并将确定新的
以及减少中风后神经血管损伤的破坏性后果的急需方法。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Receptor-interacting protein kinase 2 (RIPK2) profoundly contributes to post-stroke neuroinflammation and behavioral deficits with microglia as unique perpetrators.
受体相互作用蛋白激酶 2 (RIPK2) 极大地促进了中风后神经炎症和行为缺陷,而小胶质细胞是唯一的肇因。
- DOI:
- 发表时间:2023-09-30
- 期刊:
- 影响因子:0
- 作者:Larochelle, Jonathan;Tishko, Ryland J;Yang, Changjun;Ge, Yong;Phan, Leah T;Gunraj, Rachel E;Stansbury, Sofia M;Liu, Lei;Mohamadzadeh, Mansour;Khoshbouei, Habibeh;Candelario
- 通讯作者:Candelario
Protective roles of adropin in neurological disease.
阿德洛品在神经系统疾病中的保护作用。
- DOI:
- 发表时间:2023-03-01
- 期刊:
- 影响因子:0
- 作者:Gunraj, Rachel E;Yang, Changjun;Liu, Lei;Larochelle, Jonathan;Candelario
- 通讯作者:Candelario
Neuroinflammation, Stroke, Blood-Brain Barrier Dysfunction, and Imaging Modalities.
神经炎症、中风、血脑屏障功能障碍和成像方式。
- DOI:10.1161/strokeaha.122.036946
- 发表时间:2022-05
- 期刊:
- 影响因子:8.3
- 作者:E. C;elario;elario;R. Dijkhuizen;T. Magnus
- 通讯作者:T. Magnus
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Eduardo Jesus Candelario-Jalil其他文献
Eduardo Jesus Candelario-Jalil的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Eduardo Jesus Candelario-Jalil', 18)}}的其他基金
Role of RIPK2 in the neuroinflammatory response to ischemic stroke
RIPK2 在缺血性卒中神经炎症反应中的作用
- 批准号:
10680081 - 财政年份:2023
- 资助金额:
$ 34.52万 - 项目类别:
Multi-pronged Approach to Recalibrating the Inflammatory Cascade in Ischemic Stroke with BET blockade
通过 BET 阻断重新校准缺血性中风炎症级联的多管齐下方法
- 批准号:
10191061 - 财政年份:2019
- 资助金额:
$ 34.52万 - 项目类别:
Multi-pronged Approach to Recalibrating the Inflammatory Cascade in Ischemic Stroke with BET blockade
通过 BET 阻断重新校准缺血性中风炎症级联的多管齐下方法
- 批准号:
10636852 - 财政年份:2019
- 资助金额:
$ 34.52万 - 项目类别:
Multi-pronged Approach to Recalibrating the Inflammatory Cascade in Ischemic Stroke with BET blockade
通过 BET 阻断重新校准缺血性中风炎症级联的多管齐下方法
- 批准号:
10456172 - 财政年份:2019
- 资助金额:
$ 34.52万 - 项目类别:
Multi-pronged Approach to Recalibrating the Inflammatory Cascade in Ischemic Stroke with BET blockade
通过 BET 阻断重新校准缺血性中风炎症级联的多管齐下方法
- 批准号:
9922383 - 财政年份:2019
- 资助金额:
$ 34.52万 - 项目类别:
Neurovascular Protection by Adropin in Ischemic Stroke
Adropin 在缺血性中风中的神经血管保护作用
- 批准号:
9920225 - 财政年份:2018
- 资助金额:
$ 34.52万 - 项目类别:
Cyclooxygenase-2 Regulation of Blood-Brain Barrier Opening in Ischemic Stroke
环氧合酶 2 对缺血性中风血脑屏障开放的调节
- 批准号:
8650337 - 财政年份:2011
- 资助金额:
$ 34.52万 - 项目类别:
Cyclooxygenase-2 Regulation of Blood-Brain Barrier Opening in Ischemic Stroke
环氧合酶 2 对缺血性中风血脑屏障开放的调节
- 批准号:
8460883 - 财政年份:2011
- 资助金额:
$ 34.52万 - 项目类别:
Cyclooxygenase-2 Regulation of Blood-Brain Barrier Opening in Ischemic Stroke
环氧合酶 2 对缺血性中风血脑屏障开放的调节
- 批准号:
8827427 - 财政年份:2011
- 资助金额:
$ 34.52万 - 项目类别:
Cyclooxygenase-2 Regulation of Blood-Brain Barrier Opening in Ischemic Stroke
环氧合酶 2 对缺血性中风血脑屏障开放的调节
- 批准号:
8255462 - 财政年份:2011
- 资助金额:
$ 34.52万 - 项目类别:
相似国自然基金
跨尺度年龄自适应儿童头部模型构建与弥漫性轴索损伤行为及表征研究
- 批准号:52375281
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
年龄相关性黄斑变性治疗中双靶向药物递释策略及其机制研究
- 批准号:82301217
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
GNAS介导OPN4-PLCβ4-TRPC6/7通路调节自主感光视网膜神经节细胞在年龄相关性黄斑变性中的作用机制研究
- 批准号:82301229
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
无线供能边缘网络中基于信息年龄的能量与数据协同调度算法研究
- 批准号:62372118
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Adaptation and Implementation of Clinical Practice Guidelines to Improve Stroke Outcomes in Zambia
调整和实施临床实践指南以改善赞比亚中风结果
- 批准号:
10490455 - 财政年份:2021
- 资助金额:
$ 34.52万 - 项目类别:
NanO2 as a Cerebroprotectant in a tMCAO Stroke Model in Mice
NanO2 作为小鼠 tMCAO 中风模型中的脑保护剂
- 批准号:
10324026 - 财政年份:2021
- 资助金额:
$ 34.52万 - 项目类别:
Multi-arm Optimization of Stroke Thrombolysis (MOST) Stroke Trial
中风溶栓 (MOST) 中风试验的多臂优化
- 批准号:
10384272 - 财政年份:2021
- 资助金额:
$ 34.52万 - 项目类别:
Adaptation and Implementation of Clinical Practice Guidelines to Improve Stroke Outcomes in Zambia
调整和实施临床实践指南以改善赞比亚中风结果
- 批准号:
10369253 - 财政年份:2021
- 资助金额:
$ 34.52万 - 项目类别: